Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Endocrine hypertension in 2025: how AI and multiomics are revolutionizing detection
0
Zitationen
6
Autoren
2026
Jahr
Abstract
The convergence of multiomics and AI heralds a transformative era in EH care. While proof-of-concept studies demonstrate diagnostic accuracy comparable to invasive tests, translation into routine practice is limited by infrastructural inequities, lack of data harmonization, and gaps in clinician digital literacy. Future efforts should prioritize federated data systems, longitudinal multiomic integration, and hybrid models of human - machine collaboration. Within a decade, endocrine hypertension management will likely evolve from static, phenotype-based diagnosis to dynamic, data-driven systems medicine, integrating continuous biosensing and AI-guided decision support for truly individualized care.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.402 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.270 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.702 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.507 Zit.